Artificial Pancreas Center
APC Contact
Name:
Mary Long
Position:
Clinical Research Coordinator
111 South 11th Street
Suite 6215G
Philadelphia, PA 19107
Email:
Mary.Long@jefferson.edu
Contact Number(s):
Contact
Name:
Department of Anesthesiology & Perioperative Medicine
111 South Eleventh Street
Suite 8280
Philadelphia, PA 19107
Contact Number(s):
- 215-955-6161
- 215-923-0677 (fax)
Peer-Reviewed Publications
View the abstracts and links to the full text of all publications from the APC, or view the individual publications below.
- Joseph JI, Hipszer B. Real-time glucose monitoring in the hospital: future or now? Adv Surg 44:165-84, 2010
- Mraovic B, Hipszer BR, Epstein RH, Pequignot EC, Parvizi J, Joseph JI. Preadmission hyperglycemia is an independent risk factor for in-hospital symptomatic pulmonary embolism after major orthopedic surgery. J Arthroplasty 25:64-70, 2010
- Steil GM, Hipszer B, Reifman J. Update on mathematical modeling research to support the development of automated insulin delivery systems. J Diabetes Sci Technol 4:759-769, 2010
- Joseph JI, Hipszer B, Mraovic B, Chervoneva I, Joseph M, Grunwald Z. Clinical need for continuous glucose monitoring in the hospital. J Diabetes Sci Technol 3:1309-1318, 2009
- Mraovic B. Analysis: Continuous glucose monitoring during intensive insulin therapy. J Diabetes Sci Technol 2009 3:960-963, 2009
- Ryan MT, Savarese VW, Hipszer B, Dizdarevic I, Joseph M, Shively N, Joseph JI. Continuous glucose monitor shows potential for early hypoglycemia detection in hospitalized patients. Diabetes Technol Ther 11:745-747, 2009
- Loboda A, Kraft WK, Fine B, Joseph J, Nebozhyn M, Zhang C, He Y, Yang X, Wright C, Morris M, Chalikonda I, Ferguson M, Emilsson V, Leonardson A, Lamb J, Dai H, Schadt E, Greenberg HE, Lum PY. Diurnal variation of the human adipose transcriptome and the link to metabolic disease. BMC Med Genomics 2:7, 2009
- Tuesca AD, Reiff C, Joseph JI, Lowman AM. Synthesis, characterization and in vivo efficacy of PEGylated insulin for oral delivery with complexation hydrogels. Pharm Res 26:727-739, 2009
- Simon B, Treat V, Marco C, Rosenberg D, Joseph J, Hipszer B, Li Y, Chervoneva I, Padron-Massara L, Jabbour S. A comparison of glycaemic variability in CSII vs. MDI treated type 1 diabetic patients using CGMS. Int J Clin Pract 62:18581-1863, 2008
- Tuesca A, Nakamura K, Morishita M, Joseph J, Peppas N, Lowman A. Complexation hydrogels for oral insulin delivery: effects of polymer dosing on in vivo efficacy. J Pharm Sci 97:2607-2618, 2008
- Beilman GJ, Joseph JI. Practical considerations for glucose control in hospitalized patients. Diabetes Technol Ther 7:823-830, 2005
- Hipszer B, Joseph J, Kam M. Pharmacokinetics of intravenous insulin delivery in humans with type 1 diabetes. Diabetes Technol Ther 7:83-93, 2005
- Morishita M, Goto T, Peppas NA, Joseph JI, Torjman MC, Munsick C, Nakamura K, Yamagata T, Takayama K, Lowman AM. Mucosal insulin delivery systems based on complexation polymer hydrogels: effect of particle size on insulin enteral absorption. J Control Release 97:115-24, 2004
- Weihrauch D, Lohr NL, Mraovic B, Ludwig LM, Chilian WM, Pagel PS, Warltier DC, Kersten JR. Chronic hyperglycemia attenuates coronary collateral development and impairs proliferative properties of myocardial interstitial fluid by production of angiostatin. Circulation 109:2343-2348, 2004
- Nakamura K, Murray RJ, Joseph JI, Peppas NA, Morishita M, Lowman AM. Oral insulin delivery using P(MAA-g-EG) hydrogels: effects of network morphology on insulin delivery characteristics. J Control Release 95:589-599, 2004